A Smooth Blood Pressure Control is obtained over 24 h by Delapril in Mild to Moderate Essential Hypertensives
暂无分享,去创建一个
[1] N. Kaplan. Guidelines for the management of hypertension. , 2000, The Canadian journal of cardiology.
[2] Toshio Ogihara. Practitioner's Trial on the Efficacy of Antihypertensive Treatment in the Elderly Hypertension (The PATE-Hypertension Study) in Japan. , 2000, American journal of hypertension.
[3] V. Burke,et al. Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial. , 1999, Journal of hypertension.
[4] F. Zannad,et al. Ambulatory 24-h blood pressure assessment of the felodipine-metoprolol combination versus amlodipine in mild to moderate hypertension. Lorraine General Physician Investigators Group. , 1999, Journal of hypertension.
[5] G. Parati,et al. The smoothness index: A new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension , 1998, Journal of hypertension.
[6] M. Safar,et al. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. , 1998, Hypertension.
[7] Giuseppe Mancia,et al. Risk factors associated with alterations in carotid intima—media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis , 1998, Journal of hypertension.
[8] G. Parati,et al. The trough:peak ratio and the smoothness index in the evaluation of control of 24 h blood pressure by treatment in hypertension. , 1998, Blood pressure monitoring.
[9] S. Julius,et al. Heart rate and the cardiovascular risk , 1997, Journal of hypertension.
[10] J. Webster,et al. Ambulatory monitoring uncorrected for placebo overestimates long-term antihypertensive action. Systolic Hypertension in Europe (SYST-EUR) Trial Investigators. , 1996, Hypertension.
[11] G. Parati,et al. Calculation of trough: peak ratio of antihypertensive treatment from ambulatory blood pressure: methodological aspects , 1995, Journal of hypertension.
[12] G. Parati,et al. Lack of placebo effect on ambulatory blood pressure. , 1995, American journal of hypertension.
[13] Lipicky Rj,et al. Trough: peak ratio the rationale behind the United States Food and Drug Administration recommendations , 1994, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[14] G Mancia,et al. Prognostic value of 24-hour blood pressure variability , 1993, Journal of hypertension.
[15] P. Hjemdahl,et al. Converting enzyme inhibition modulates sympathetic neurotransmission in vivo via multiple mechanisms. , 1993, The American journal of physiology.
[16] K. Arakawa,et al. Effects of manidipine and delapril on serum lipids, lipoproteins, and apolipoproteins in patients with mild to moderate essential hypertension: a randomized trial with one-year follow-up. , 1992, Clinical Therapeutics.
[17] P. Palatini,et al. Clinical relevance of nighttime blood pressure and of daytime blood pressure variability. , 1992, Archives of internal medicine.
[18] A. Dupont,et al. Placebo does not lower ambulatory blood pressure. , 1987, British journal of clinical pharmacology.
[19] R S Paffenbarger,et al. Heart rate and cardiovascular mortality: the Framingham Study. , 1987, American heart journal.
[20] G Parati,et al. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. , 1987, Journal of hypertension.
[21] J. Ferlinz. DOES PLACEBO LOWER BLOOD PRESSURE? , 1982, The Lancet.
[22] F. Zannad,et al. Double-blind, randomized, multicentre comparison of the effects of amlodipine and perindopril on 24 h therapeutic coverage and beyond in patients with mild to moderate hypertension , 1999 .
[23] R. Dietz,et al. Improvement of vagal tone by ACE inhibition: a mechanism of cardioprotection in patients with mild-to-moderate heart failure. , 1996, Journal of cardiovascular pharmacology.
[24] H. Matsuoka. A 12-month comparison of ACE inhibitor and CA antagonist therapy in mild to moderate essential hypertension--The GLANT Study. Study Group on Long-term Antihypertensive Therapy. , 1995, Hypertension research : official journal of the Japanese Society of Hypertension.
[25] T. Ogihara,et al. Effect of long-term treatment with delapril on quality of life in hypertensive patients , 1992 .
[26] Y. Yamada,et al. A study of the effects of delapril, a new angiotensin converting enzyme inhibitor, on the diurnal variation of arterial pressure in patients with essential hypertension using indirect and direct arterial pressure monitoring methods. , 1991, American journal of hypertension.
[27] T. Saruta,et al. Characteristics of a new angiotensin converting enzyme inhibitor: delapril. , 1991, American journal of hypertension.
[28] T. Ogihara,et al. Clinical evaluation of delapril in Japan. Report from the Japan Study Group on Delapril. , 1991, American journal of hypertension.